MedPath

Cholestyramine

Generic Name
Cholestyramine
Brand Names
Prevalite, Questran
Drug Type
Small Molecule
CAS Number
11041-12-6
Unique Ingredient Identifier
4B33BGI082

Overview

Cholestyramine or colestyramine is a bile acid sequestrant. Bile acid sequestrants are polymeric compounds which serve as ion exchange resins. Cholestyramine resin is quite hydrophilic, but insoluble in water.

Background

Cholestyramine or colestyramine is a bile acid sequestrant. Bile acid sequestrants are polymeric compounds which serve as ion exchange resins. Cholestyramine resin is quite hydrophilic, but insoluble in water.

Indication

Indicated as adjunctive therapy to diet for the reduction of elevated serum cholesterol in patients with primary hypercholesterolemia (elevated low density lipoprotein [LDL] cholesterol) who do not respond adequately to diet. Also for the relief of pruritus associated with partial biliary obstruction.

Associated Conditions

  • Atherosclerosis
  • Primary Hypercholesterolemia
  • Pruritus

FDA Approved Products

cholestyramine powder for suspension
Manufacturer:Bryant Ranch Prepack
Route:ORAL
Strength:4 g in 8.780 g
Approved: 2024/03/08
NDC:72162-1834
Cholestyramine
Manufacturer:Eon Labs, Inc.
Route:ORAL
Strength:4 g in 9 g
Approved: 2020/08/11
NDC:0185-0940
Cholestyramine
Manufacturer:Physicians Total Care, Inc.
Route:ORAL
Strength:4 g in 5 g
Approved: 2010/04/28
NDC:54868-5526
Cholestyramine
Manufacturer:Physicians Total Care, Inc.
Route:ORAL
Strength:4 g in 9 g
Approved: 2010/04/28
NDC:54868-4812
CHOLESTYRAMINE LIGHT
Manufacturer:EPIC PHARMA, LLC
Route:ORAL
Strength:4 g in 5.7 g
Approved: 2021/12/15
NDC:42806-269

Singapore Approved Products

PMS-CHOLESTYRAMINE POWDER
Manufacturer:PHARMALAB INC
Form:POWDER
Strength:4.00 g
Online:Yes
Approved: 1993/05/12
Approval:SIN07426P
RESINCOLESTIRAMINA POWDER
Manufacturer:LABORATORIOS RUBIO SA
Form:POWDER
Strength:4 g/sachet
Online:Yes
Approved: 1991/09/27
Approval:SIN06583P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath